アンジオテンシン II 受容体拮抗薬 : カンデサルタン シレキセチルの創製

DOI Web Site Web Site 被引用文献1件 参考文献30件

書誌事項

タイトル別名
  • Angiotensin II Receptor Antagonists : Candesartan Cilexetil
  • アンジオテンシン 2 ジュヨウタイ キッコウヤク カンデサルタン シレキセチル ノ ソウセイ

この論文をさがす

説明

Blockade of the action of angiotensin II (AII) has long been a target for the development of novel antihypertensive agents. We recently discovered a novel class of potent nonpeptide AII receptor antagonists, benzimidazole-7-carboxylic acids including candesartan. Candesartan is a highly potent and insurmountable AII type-1 receptor (AT1)-selective antagonist. Structure-activity relationship (SAR) studies revealed that the adjacent arrangement of a lipophilic substituent, a tetrazolylbiphenylmethyl moiety and a carboxyl group was the important structural requirement for potent AII antagonistic activity. Especially, the presence of a carboxyl group at the 7-position was found to be essential for insurmountable antagonism. To improve bioavailability of candesartan, chemical modification was examined to yield candesartan cilexetil, a prodrug of candesartan. Candesartan cilexetil is a potent and long-acting blocker that, when given once a day to patients, provides effective 24 hr blood pressure control.

収録刊行物

  • 薬学雑誌

    薬学雑誌 120 (12), 1261-1275, 2000

    公益社団法人 日本薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (30)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ